VIDA

VIDA is a lung health company that modernizes respiratory care by leveraging artificial intelligence to enhance patient outcomes and streamline care coordination. The company provides healthcare organizations and physicians with advanced quantitative data intelligence and impactful visualizations, enabling effective management of patients with chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), lung cancer, and COVID-19. VIDA's software is FDA cleared, CE-marked, Health Canada licensed, and TGA registered, allowing for clinical use in the United States, European Economic Area, Canada, and Australia. Additionally, VIDA offers a comprehensive suite of clinical trial services, which includes advanced quantitative image analysis and support for trial data enhancement, site quality services, and subject screening, thus contributing to the acceleration of new therapies for patients.